Notably, MEK inhibition has resulted in reduced seizure activity in mouse models of TSC [11] and in the Krushinsky–Molodkina rat [17], a genetic rat model of audiogenic seizures in which increased ERK activation is observed in glutamatergic neurons [18]. Here, MAP2K7 is linked to tuberous sclerosis.